Amedeo Smart

Free Medical Literature Service



Ovarian Neoplasms

  Free Subscription

Articles published in
    September 2020
  1. STEFFEN T, Haller L, Bijelic L, Glatzer M, et al
    Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI).
    Oncology. 2020 Sep 11:1-8. doi: 10.1159/000510098.
    >> Share

    January 2020
  2. EBATA T, Yonemori K, Nishikawa T, Sudo K, et al
    Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma.
    Oncology. 2020;98:699-705.
    >> Share

    August 2019
  3. PALAIA I, Tomao F, Santangelo G, Di Pinto A, et al
    The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life.
    Oncology. 2019 Aug 22:1-5. doi: 10.1159/000501721.
    >> Share

    July 2019
    The Evolving Arena of Ovarian Cancer Maintenance Therapy.
    Oncology. 2019 Jul 9:1-4. doi: 10.1159/000501618.
    >> Share

    January 2019
  5. MIYAMOTO M, Takano M, Tsuda H, Matuura H, et al
    Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas.
    Oncology. 2019;96:93-100.
    >> Share

  6. LALISCIA C, Cosio S, Morganti R, Mazzotti V, et al
    Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.
    Oncology. 2019;96:235-241.
    >> Share

    July 2018
  7. SEKINE K, Hamaguchi T, Shoji H, Takashima A, et al
    Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.
    Oncology. 2018 Jul 20:1-9. doi: 10.1159/000489665.
    >> Share

    January 2018
  8. KEMILAINEN H, Huhtinen K, Auranen A, Carpen O, et al
    The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer.
    Oncology. 2018 Jan 12. pii: 000485624. doi: 10.1159/000485624.
    >> Share

    September 2017
  9. MARCHETTI C, Musella A, Romito A, Vertechy L, et al
    Short-Infusion Trabectedin in Heavily Pretreated Ovarian Cancer Patients: A Single-Institution Experience.
    Oncology. 2017 Sep 26. doi: 10.1159/000475668.
    >> Share

    August 2017
  10. CORTESI L, De Matteis E, Toss A, Marchi I, et al
    Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
    Oncology. 2017 Aug 26. doi: 10.1159/000479155.
    >> Share

    October 2016
  11. AKLADIOS C, Baldauf JJ, Marchal F, Hummel M, et al
    Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?
    Oncology. 2016.
    >> Share

    January 2016
  12. LEMECH CR, Ensell L, Paterson JC, Eminowicz G, et al
    Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
    Oncology. 2016;91:48-54.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016